Mitchell Kapoor

H.C. Wainwright & Co.

Recent Articles about MeiraGTx Holdings Plc

Company Wins Back Promising Eye Disease Drug and Eyes Two Product Launches by 2028 04/20/2026

MeiraGTx Holdings plc. (MGTX:NASDAQ) reported three-year durability data for AAV-hAQP1 in radiation-induced xerostomia, the reacquisition of filing-ready XLRP asset bota-vec from Johnson & Johnson, and a US$100M, according to an H.C. Wainwright research note.